Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
MONDOA forms heterodimers with MLX (MIM 602976) that can bind to and activate transcription from CACGTG E boxes (Billin et al., 2000. Additionally we are shipping MLX Interacting Protein Proteins (4) and MLX Interacting Protein Kits (2) and many more products for this protein.
Showing 10 out of 32 products:
Human Polyclonal MLXIP Primary Antibody for EIA, IHC (p) - ABIN953462
Peterson, Stoltzman, Sighinolfi, Han, Ayer: Glucose controls nuclear accumulation, promoter binding, and transcriptional activity of the MondoA-Mlx heterodimer. in Molecular and cellular biology 2010
Show all 5 references for ABIN953462
Human Polyclonal MLXIP Primary Antibody for WB - ABIN610684
Das, Lewis, Scherer, Lisanti: The membrane-spanning domains of caveolins-1 and -2 mediate the formation of caveolin hetero-oligomers. Implications for the assembly of caveolae membranes in vivo. in The Journal of biological chemistry 1999
Show all 3 references for ABIN610684
Dog (Canine) Polyclonal MLXIP Primary Antibody for WB - ABIN2776519
Stoltzman, Peterson, Breen, Muoio, Billin, Ayer: Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression. in Proceedings of the National Academy of Sciences of the United States of America 2008
Evaluation of the conservation of ChREBP (show MLXIPL Antibodies) and MondoA sequences demonstrate that MondoA is better conserved and potentially mediates more ancient function in glucose metabolism.
These results suggest that C771G polymorphism of MLXIPL (show MLXIPL Antibodies) gene is associated with coronary stenosis and its severity.
Knockdown of MondoA, or its dimerization partner Mlx (show MLX Antibodies), blocks Myc (show MYC Antibodies)-induced reprogramming of multiple metabolic pathways, resulting in apoptosis
regulatory relationship between mTOR (show FRAP1 Antibodies) and the MondoA-TXNIP (show TXNIP Antibodies) axis that we propose contributes to glucose homeostasis
Suppression of Txnip (show TXNIP Antibodies) by lipopolysaccharide is accompanied by a decrease of the glucose sensing transcription factor MondoA in the nuclei.
An important contribution of MondoA to leukemia aggressiveness, which makes MondoA a potential candidate for targeted treatment of acute lymphoblastic leukemia.
the MondoA-TXNIP (show TXNIP Antibodies) regulatory circuit has a role in the hexose transport curb, although other redundant pathways also contribute
Induction of TXNIP (show TXNIP Antibodies) under lactic acidosis is caused by the activation of the glucose-sensing helix-loop-helix transcriptional complex MondoA:Mlx, which is usually triggered upon glucose exposure.
Glucose is required at two additional steps to stimulate the transcription activation function of MondoA-Mlx (show MLX Antibodies) complexes.
Data show that for both MondoA and Mlx (show MLX Antibodies), the C-terminal domain CRM-1 (show XPO1 Antibodies) has cytoplasmic localization activity that is required by the protein monomers to accumulate in the cytoplasm.
MondoA is a basic helix-loop-helix/leucine zipper transcription factor (show NRL Antibodies) that is expressed predominantly in skeletal muscle. Mice deficient for MondoA excel in sprinting, as their skeletal muscles display an enhanced glycolytic capacity.
MondoA-Mlx (show MLX Antibodies) complexes sense elevated levels of G6P and adenine nucleotides to trigger a TXNIP (show TXNIP Antibodies)-dependent feedback inhibition of glycolysis
MONDOA forms heterodimers with MLX (MIM 602976) that can bind to and activate transcription from CACGTG E boxes (Billin et al., 2000
MLX interacting protein
, MLX-interacting protein-like
, MLX-interacting protein
, Mlx interactor
, class E basic helix-loop-helix protein 36
, transcriptional activator MondoA